EQNR Financial Statements & Analysis
Complete financial statements for EQNR including income statement, balance sheet, and cash flow statement. Analyze EQNR's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
3.6% ↑
Net Income
-42.6% ↓
Gross Margin
-35.5% ↓
Operating Margin
-14.8% ↓
Balance Sheet
Current Ratio
-15.8% ↓
Debt to Equity
16.4% ↓
Asset Turnover
3.1% ↑
Cash Flow
Operating Cash Flow
-0.4% ↓
Net Cash Flow
43.0% ↑
Free Cash Flow
-24.4% ↓
Cash Flow to Debt
-10.4% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 102.50B | 106.16B | 3.6% | |
| Gross Profit | 42.63B | 28.50B | 33.2% | |
| Operating Income | 30.93B | 27.28B | 11.8% | |
| Net Income | 8.81B | 5.06B | 42.6% | |
| EPS | 3.12 | 1.95 | 37.5% | |
| EBITDA | 41.95B | 36.46B | 13.1% | |
| Gross Margin | 41.59% | 26.84% | 35.5% | |
| Operating Margin | 30.17% | 25.70% | 14.8% | |
| Net Income Margin | 8.59% | 4.77% | 44.5% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 106.16B | 102.50B | 106.85B | — | — |
| Gross Profit | 28.50B | 42.63B | 48.04B | — | — |
| Operating Income | 27.28B | 30.93B | 35.77B | — | — |
| Net Income | 5.06B | 8.81B | 11.88B | — | — |
| EPS | 1.95 | 3.12 | 3.93 | — | — |
| EBITDA | 36.46B | 41.95B | 49.59B | — | — |
| Gross Margin | 26.84% | 41.59% | 44.96% | — | — |
| Operating Margin | 25.70% | 30.17% | 33.48% | — | — |
| Net Income Margin | 4.77% | 8.59% | 11.12% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into EQNR's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics